All pages with prefix
Jump to navigation
Jump to search
- Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
- Trans-2-Phenyl-1-cyclohexanol
- Trans-2-decenoyl-(acyl-carrier protein) isomerase
- Trans-2-enoyl-CoA reductase (NAD+)
- Trans-2-enoyl-CoA reductase (NADPH)
- Trans-L-3-hydroxyproline dehydratase
- Trans-acenaphthene-1,2-diol dehydrogenase
- Trans-aconitate 2-methyltransferase
- Trans-aconitate 3-methyltransferase
- Trans-acting
- Trans-activation response element (TAR)
- Trans-cinnamate 2-monooxygenase
- Trans-cinnamate 4-monooxygenase
- Trans-cis isomerization
- Trans-epoxysuccinate hydrolase
- Trans-feruloyl-CoA hydratase
- Trans-feruloyl-CoA synthase
- Trans-hexaprenyltranstransferase
- Trans-octaprenyltranstransferase
- Trans-pentaprenyltranstransferase
- Trans-splicing
- Trans-tubular potassium gradient
- Trans-zeatin O-beta-D-glucosyltransferase
- TransMolecular
- Trans effect
- Trans fat
- Transactinide element
- Transactional analysis
- Transactivation
- Transactive memory
- Transaldolase
- Transaldolase 1
- Transaminase
- Transamination
- Transannular interaction
- Transatlantic Partners Against AIDS
- Transcare
- Transcatheter aortic valve replacement
- Transcatheter arterial chemoembolization
- Transcellular fluid
- Transcendence (philosophy)
- Transcobalamin
- Transcobalamins
- Transcortical motor aphasia
- Transcortical sensory aphasia
- Transcortin
- Transcranial direct current stimulation
- Transcranial doppler
- Transcranial magnetic stimulation
- Transcript of unknown function
- Transcription-coupled repair
- Transcription (genetics)
- Transcription Factor II A
- Transcription Factor II B
- Transcription Factor II D
- Transcription Factor II E
- Transcription Factor II F
- Transcription Factor II H
- Transcription bubble
- Transcription coregulator
- Transcription elongation regulator 1
- Transcription factor
- Transcription factor 3 gene transcriptions
- Transcription factor AP-1
- Transcription factor IIIB 50 kDa subunit
- Transcription factor II A
- Transcription factor II B
- Transcription factor II E
- Transcription factor II F
- Transcription factor II H
- Transcription factor gene transcriptions
- Transcription initiation protein SPT3 homolog
- Transcription start sites
- Transcription termination factor, RNA polymerase I
- Transcriptional regulation
- Transcriptome
- Transcritical cycle
- Transcultural nursing
- Transcutaneous Electrical Nerve Stimulator
- Transcutaneous pacing
- Transcytosis
- Transderivational search
- Transdermal
- Transdermal implant
- Transdermal patch
- Transdifferentiation
- Transdisciplinarity
- Transducin
- Transduction
- Transduction (biophysics)
- Transduction (genetics)
- Transduction (machine learning)
- Transduction (physiology)
- Transect
- Transepidermal water loss
- Transesophageal echo cardiography
- Transesophageal echocardiography (TEE)
- Transesterification
- Transfection
- Transfer RNA
- Transfer factor
- Transfer hydrogenation
- Transfer of mitochondrial and chloroplast DNA to the nucleus
- Transferability
- Transferability (chemistry)
- Transferable belief model
- Transferase
- Transference
- Transferrin
- Transferrin receptor
- Transferrin receptor 1
- Transferrin receptor 2
- Transferrin saturation
- Transfersome
- Transfluthrin
- Transformation/transcription domain-associated protein
- Transformation (genetics)
- Transforming Faces Worldwide
- Transforming growth factor
- Transforming growth factor, beta 3
- Transforming growth factor beta superfamily
- Transfusion-associated graft versus host disease
- Transfusion-associated graft versus host disease (patient information)
- Transfusion-associated graft versus host disease HLA analysis
- Transfusion-associated graft versus host disease biomarker panel
- Transfusion-associated graft versus host disease case study one
- Transfusion-associated graft versus host disease causes
- Transfusion-associated graft versus host disease chest x ray
- Transfusion-associated graft versus host disease classification
- Transfusion-associated graft versus host disease cost-effectiveness of therapy
- Transfusion-associated graft versus host disease differential diagnosis
- Transfusion-associated graft versus host disease epidemiology and demographics
- Transfusion-associated graft versus host disease future or investigational therapies
- Transfusion-associated graft versus host disease historical perspective
- Transfusion-associated graft versus host disease history and symptoms
- Transfusion-associated graft versus host disease laboratory findings
- Transfusion-associated graft versus host disease medical therapy
- Transfusion-associated graft versus host disease natural history, complications and prognosis
- Transfusion-associated graft versus host disease other diagnostic studies
- Transfusion-associated graft versus host disease other imaging findings
- Transfusion-associated graft versus host disease overview
- Transfusion-associated graft versus host disease pathophysiology
- Transfusion-associated graft versus host disease physical examination
- Transfusion-associated graft versus host disease primary prevention
- Transfusion-associated graft versus host disease risk factors
- Transfusion-associated graft versus host disease screening
- Transfusion-associated graft versus host disease secondary prevention
- Transfusion-associated graft versus host disease skin punch biopsy
- Transfusion-associated graft versus host disease surgery
- Transfusion-associated graft versus host disease ultrasound
- Transfusion-related immunomodulation
- Transfusion Transmitted Virus
- Transfusion hemosiderosis
- Transfusion in ACS management
- Transfusion medicine
- Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients
- Transfusion reaction
- Transfusion related acute lung injury
- Transfusion therapy resident survival guide
- Transgelin
- Transgene
- Transgenic bacteria
- Transgenic maize
- Transgenic plant
- Transglutaminase
- Transglutamination
- Transgressive segregation
- Transheterozygote
- Transhumeral prosthesis
- Transient erythroblastopenia of childhood
- Transient flow
- Transient hypogammaglobulinemia of infancy
- Transient ischemic attack
- Transient ischemic attack (patient information)
- Transient ischemic attack CT
- Transient ischemic attack MRI
- Transient ischemic attack case study one
- Transient ischemic attack causes
- Transient ischemic attack cost-effectiveness of therapy
- Transient ischemic attack differential diagnosis
- Transient ischemic attack echocardiography
- Transient ischemic attack electrocardiogram
- Transient ischemic attack epidemiology and demographics
- Transient ischemic attack future or investigational therapies
- Transient ischemic attack historical perspective
- Transient ischemic attack history and symptoms
- Transient ischemic attack laboratory findings
- Transient ischemic attack medical therapy
- Transient ischemic attack natural history, complications and prognosis
- Transient ischemic attack other diagnostic studies
- Transient ischemic attack other imaging findings
- Transient ischemic attack overview
- Transient ischemic attack pathophysiology
- Transient ischemic attack physical examination
- Transient ischemic attack primary prevention
- Transient ischemic attack risk factors
- Transient ischemic attack secondary prevention
- Transient ischemic attack surgery
- Transient ischemic attack ultrasound
- Transient neurological attack
- Transient receptor potential
- Transient receptor potential channel
- Transient state (chemical engineering)
- Transient synovitis
- Transient tachypnea of the newborn
- Transient tic disorder (patient information)
- Transillumination
- Transiogram
- Transistasis
- Transistor
- Transition
- Transition (genetics)
- Transition metal
- Transition metal carbene complex
- Transition nuclear protein
- Transition of care
- Transition state
- Transition to adult care
- Transitional care
- Transitional cell carcinoma
- Transitional cell carcinoma (patient information)
- Transitional cell carcinoma CT
- Transitional cell carcinoma MRI
- Transitional cell carcinoma case study one
- Transitional cell carcinoma causes
- Transitional cell carcinoma chest x ray
- Transitional cell carcinoma classification
- Transitional cell carcinoma cost-effectiveness of therapy
- Transitional cell carcinoma cystoscopy and bladder biopsy
- Transitional cell carcinoma differential diagnosis
- Transitional cell carcinoma electrocardiogram
- Transitional cell carcinoma epidemiology and demographics
- Transitional cell carcinoma future or investigational therapies
- Transitional cell carcinoma historical perspective
- Transitional cell carcinoma history and symptoms
- Transitional cell carcinoma laboratory findings
- Transitional cell carcinoma medical therapy
- Transitional cell carcinoma natural history
- Transitional cell carcinoma natural history, complications and prognosis
- Transitional cell carcinoma other diagnostic studies
- Transitional cell carcinoma other imaging findings
- Transitional cell carcinoma overview
- Transitional cell carcinoma pathophysiology
- Transitional cell carcinoma physical examination
- Transitional cell carcinoma primary prevention
- Transitional cell carcinoma risk factors
- Transitional cell carcinoma screening
- Transitional cell carcinoma secondary prevention
- Transitional cell carcinoma staging
- Transitional cell carcinoma surgery
- Transitional cell carcinoma ultrasound
- Transitional epithelium
- Transitional object
- Transjugular intrahepatic portosystemic shunt
- Transjugular intrahepatic portosystemic shunt (patient information)